Trans Vagina: How Surgery Works, Depth, and Sensation

A neovagina created through gender-affirming vaginoplasty is a surgically constructed vaginal canal and vulva, built from a transgender woman’s own tissue. The most widely used method, penile inversion vaginoplasty, reshapes penile and scrotal skin into the vaginal lining, while newer techniques use peritoneal tissue or segments of the colon. Across surgical approaches, pooled data show an overall satisfaction rate of about 91%, though the procedure involves a significant recovery period and carries real risks that are worth understanding in detail.

How the Surgery Works

Penile inversion vaginoplasty, often abbreviated PIV, remains the most common approach worldwide. The surgeon uses the skin of the penis, turned inside out, to line the new vaginal canal. Scrotal skin often provides additional lining material. A clitoris is fashioned from the glans of the penis, preserving the nerve bundle so sensation remains possible. The urethra is shortened and repositioned, and the external appearance of the vulva, including labia, is sculpted from surrounding tissue.

Peritoneal flap vaginoplasty is a newer technique that uses the peritoneum, the thin membrane lining the abdominal cavity, to create the vaginal canal. This approach is often performed with robotic assistance. A comparative study found that peritoneal flap procedures yielded greater vaginal depth than penile inversion at both one month and six months after surgery, even in patients who started with less penile skin to work with.

A third option, intestinal or sigmoid colon vaginoplasty, uses a segment of the bowel to line the canal. This technique tends to produce the greatest depth on average, around 15 cm compared to roughly 9 to 10 cm for penile inversion, though it involves abdominal surgery and carries distinct risks related to the bowel.

Vaginal Depth and Why Technique Matters

Depth is one of the most discussed outcomes, and it varies substantially depending on the method used and the amount of tissue available. A meta-analysis of transfeminine vaginoplasty found average neovaginal depth was about 9.4 cm for penile skin inversion and about 15.3 cm for intestinal vaginoplasty.¹ In studies of robotic peritoneal flap vaginoplasty, mean depth was in the 13 to 14 cm range, with some patients reaching over 18 cm at follow-up.²

Depth matters to some patients more than others, and it is not the only marker of a successful outcome. Some transgender women prioritize external appearance, sensation, or simply having anatomy that aligns with their identity. For those who do want penetrative vaginal intercourse, depth and width both influence comfort during sex, and surgeons typically discuss realistic expectations based on the patient’s anatomy before choosing a technique.

Sensation and Orgasm After Surgery

One of the most common concerns before vaginoplasty is whether genital sensation will survive the procedure. Because the clitoris is constructed from the glans penis with its nerve supply preserved, most patients retain the capacity for clitoral sensation. In a multicenter study of sexually active trans women, about two-thirds reported that the clitoris had “sufficient sensitivity.”³

Orgasm rates are encouraging but not universal. One survey using a validated questionnaire found that roughly half of respondents were always or almost always able to reach orgasm when they wanted to, and about two-thirds were satisfied with their orgasm quality.⁴ About half of patients in that study noticed pleasurable genital sensations within three months of surgery. A separate large study found that 80% of patients who could orgasm before surgery continued to do so afterward, and 29% of those who had never orgasmed before surgery achieved orgasm for the first time after vaginoplasty.⁵

That said, masturbation was the most frequent sexual activity that reliably led to orgasm in the multicenter study, and lubrication scored the lowest among all sexual function domains.⁶ The type of surgery also makes a difference: one study found significant differences in the ability to reach orgasm through vaginal penetration, clitoral stimulation, and anal penetration depending on the vaginoplasty technique used.⁷

Lubrication

Self-lubrication is a real but limited reality for most neovaginas, and expectations here deserve honest framing. A penile inversion neovagina is lined with skin, which does not naturally produce vaginal-type lubrication. Some moisture comes from periurethral glands and residual tissue, but most patients will need supplemental lubricant for comfortable intercourse. One satisfaction study found that 69% of patients were satisfied with their lubrication and that about half reported fluid release during orgasm.⁸

Peritoneal and colon-based vaginoplasties do use tissue with secretory capacity, but the fluid these tissues produce is continuous rather than responsive to sexual arousal, and the volume can be more than some patients expect or want.⁹ In practical terms, this means some patients with intestinal vaginoplasties manage chronic discharge rather than dryness, which presents its own quality-of-life challenges.

How the Neovaginal Microbiome Differs

The bacterial community inside a neovagina is distinct from a cisgender vagina, and understanding that difference matters for health screening and infection management. A cisgender vagina is typically dominated by Lactobacillus, which produces lactic acid and keeps the pH low. A neovagina created by penile inversion tends to harbor a more diverse mix of bacteria, with species like Porphyromonas, Prevotella, and Mobiluncus predominating instead of Lactobacillus.¹⁰ An early culture-based study of 30 post-operative trans women found Lactobacilli in only one patient, and the average number of species per woman was about nine, a much more complex ecosystem than a typical cisgender vagina.¹¹

A systematic review comparing techniques found that penile inversion neovaginas most closely resembled cisgender vaginas with bacterial vaginosis, while intestinal vaginoplasties had microbiomes more like the colon, which makes sense given the source tissue.¹² This does not mean the neovagina is “infected.” It means clinicians need to interpret lab results differently. A Gram stain that would signal bacterial vaginosis in a cisgender patient may simply reflect the normal baseline flora of a neovagina. Using the wrong reference point could lead to unnecessary antibiotic treatment.

Complications and Revision Surgery

Vaginoplasty is major surgery, and complication rates reflect that. The most frequently reported issue is neovaginal stenosis, a narrowing or loss of depth. A systematic review covering nearly 7,400 patients found stenosis in about 6% of cases, with introital strictures adding another 3%, for a combined incidence of roughly 10%.¹³ The definition of stenosis was inconsistent across studies, so those numbers should be understood as approximate. A meta-analysis reported a pooled stenosis and stricture rate of about 11%.¹⁴

Fistulas, abnormal connections between the neovagina and the rectum or urethra, are rarer but serious. One large series reported treating fistulas in about 2% of patients, with rectoneovaginal fistulas making up about half of cases.¹⁵ Revision vaginoplasty carried a substantially higher risk: patients undergoing a second procedure had a rectoneovaginal fistula rate over eight times that of first-time patients.¹⁶ Most fistulas were repaired with local flap surgery or primary closure, though some required a temporary colostomy.¹⁷

Other reported complications include tissue necrosis in about 4% of cases and prolapse in about 3%.¹⁸ Revision surgery for cosmetic or functional concerns is common, covering everything from labiaplasty touch-ups to urethral repositioning to treatment of internal strictures.¹⁹

Dilation and Pelvic Floor Therapy

After vaginoplasty, regular dilation of the neovaginal canal is essential to prevent it from narrowing or closing. The body treats the canal as a wound and will attempt to contract it over time, so patients use graduated dilators on a schedule that starts frequent (multiple times per day) and gradually tapers over months. One program reported successful dilation at three months in 89% of patients.²⁰ Dilation remains a lifelong commitment, though the frequency decreases substantially after the first year for most people.

Pelvic floor physical therapy has emerged as an important adjunct. A program that screened patients before surgery found that 42% already had pelvic floor dysfunction and 37% had bowel dysfunction going in.²¹ Patients who attended pelvic floor therapy both before and after surgery had dramatically lower rates of ongoing pelvic floor problems compared to those who started therapy only after the procedure. A scoping review confirmed that pre- and post-operative pelvic floor therapy improved ease of dilation and overall pelvic function.²² Common post-surgical issues that benefit from therapy include urinary incontinence, prolonged pelvic pain, and difficulty with the dilation routine.²³

Why Hair Removal Before Surgery Matters

Because penile and scrotal skin carry hair follicles, and that skin is used to line the vaginal canal, preoperative hair removal is a critical preparatory step. If hair-bearing skin is used without adequate treatment, patients can develop hair growth inside the neovagina, which leads to chronic irritation, folliculitis, infections, malodor, and in rare cases, hairballs or calculi that require additional procedures to remove.²⁴ Electrolysis has traditionally been the standard because it works regardless of hair color, but laser hair removal is increasingly considered a first-line option for eligible patients because it covers larger areas more quickly. Most surgical programs require a course of hair removal spanning several months before the operation date.

Long-Term Screening Considerations

A neovagina does not carry the same cancer risks as a cisgender vagina, but it is not risk-free. The prostate gland is not removed during vaginoplasty, and while long-term estrogen therapy dramatically lowers PSA levels, prostate cancer remains a theoretical possibility. Current screening guidelines were not designed with transgender women in mind, and researchers have called for revised protocols that account for the effect of hormone therapy on PSA.²⁵

HPV-related changes have also been documented in neovaginal tissue. A cytology study of neovaginal samples found atypical cells in a small proportion of patients, including one case of high-grade dysplasia positive for high-risk HPV.²⁶ In patients with peritoneal flap vaginoplasty, biopsies have shown that the peritoneal lining undergoes metaplasia, transforming into stratified squamous epithelium, and some of these biopsies showed features that mimic low-grade dysplasia on pathology slides, which complicates interpretation.²⁷ The clinical significance of these findings is still being studied, but they suggest that routine gynecological follow-up for trans women with neovaginas is reasonable, even if the screening protocols need to be adapted from standard cervical cancer screening.

Vulvoplasty as an Alternative

Not every transgender woman wants or needs a vaginal canal. Vulvoplasty, sometimes called zero-depth or minimal-depth vaginoplasty, creates the external vulvar anatomy, including labia, clitoral hood, and clitoris, without constructing a vaginal canal. This is a shorter procedure with a faster recovery and eliminates the need for lifelong dilation. In one study, 93% of patients who chose vulvoplasty were satisfied with both the surgery and their decision.²⁸ For patients whose dysphoria centers on external anatomy rather than the absence of a vaginal canal, or for those who do not plan to have penetrative vaginal sex, vulvoplasty can be the better fit.

Mental Health and Quality of Life After Surgery

The psychiatric and quality-of-life data broadly support vaginoplasty as effective for its intended purpose. A systematic review of longitudinal cohort studies found that gender-affirming surgery was associated with a significant reduction in gender dysphoria and an initial improvement in quality of life.²⁹ The regret rate across pooled studies sits at roughly 2%.³⁰

Sexual satisfaction after surgery does not hinge on a single factor. The data show it is not predicted by age, race, type of surgery, or whether the patient needed a revision. Instead, the strongest predictors of sexual satisfaction were the ability to orgasm after surgery and the absence of pain during orgasm.³¹ Higher scores on body image and social acceptance scales also tracked with better sexual well-being, which suggests that surgery is one part of a larger picture that includes social support and psychological adjustment.

The Evolving Landscape of Tissue and Technique

Peritoneal flap vaginoplasty has grown rapidly since robotic-assisted platforms made the procedure more accessible. The tissue undergoes a biological transformation once it is placed in the vaginal position: biopsies show that peritoneal mesothelium converts into stratified squamous epithelium over time, a process called metaplasia.³² Whether this transformation improves long-term outcomes, reduces the need for lubrication, or changes complication rates compared to skin-lined canals is still an open question. Early data on depth are promising, with one comparative study showing peritoneal flaps maintaining about 18 cm at six months versus 15 cm for penile inversion.³³

Tissue engineering is another frontier, though it remains largely experimental for transgender applications. Biomaterial-based scaffolds have been used successfully in patients born without a vagina due to congenital conditions, with one study reporting a 100% anatomic success rate and high satisfaction at roughly two years of follow-up.³⁴ Translating that approach to gender-affirming surgery would be complex, but the principle of growing new tissue on a scaffold rather than repurposing existing anatomy could eventually expand options for patients with limited donor tissue. For now, the three established approaches, penile inversion, peritoneal flap, and intestinal vaginoplasty, remain the clinical standard, with technique selection guided by the patient’s anatomy, goals, and tolerance for each procedure’s trade-offs.